Xospata 40Mg C/ 84 Comp
Gilteritinibe is a 40 mg oral tablet used to treat acute myeloid leukemia with FLT3 mutation, either relapsed or refractory.
- The description claims the medication is contraindicated in cases of known gilteritinibe or formula component hypersensitivity.
- The description claims the medication is category C for pregnancy and should not be used by pregnant women without medical advice.
- The description claims safety and efficacy in children under 18 years old have not been established.
AI Readiness
Good foundation, but some important product data is still missing.
80%